Entity Details

Primary name PAFA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ13093
EntryNamePAFA_HUMAN
FullNamePlatelet-activating factor acetylhydrolase
TaxID9606
Evidenceevidence at protein level
Length441
SequenceStatuscomplete
DateCreated1997-11-01
DateModified2021-06-02

Ontological Relatives

GenesPLA2G7

GO terms

Show/Hide Table
GOName
GO:0003847 1-alkyl-2-acetylglycerophosphocholine esterase activity
GO:0005543 phospholipid binding
GO:0005576 extracellular region
GO:0005737 cytoplasm
GO:0034362 low-density lipoprotein particle
GO:0034364 high-density lipoprotein particle
GO:0034374 low-density lipoprotein particle remodeling
GO:0034440 lipid oxidation
GO:0034441 plasma lipoprotein particle oxidation
GO:0034638 phosphatidylcholine catabolic process
GO:0046469 platelet activating factor metabolic process
GO:0047499 calcium-independent phospholipase A2 activity
GO:0050729 positive regulation of inflammatory response
GO:0062234 platelet activating factor catabolic process
GO:0090026 positive regulation of monocyte chemotaxis

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR005065 Platelet-activating factor acetylhydrolase-likeFamilyFamily
IPR016715 Platelet-activating factor acetylhydrolase, eucaryoteFamilyFamily
IPR029058 Alpha/Beta hydrolase foldFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614278 OMIMPlatelet-activating factor acetylhydrolase deficiency (PAFAD)An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms. The disease is caused by variants affecting the gene represented in this entry.
600807 OMIMAsthma (ASTHMA)The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi. Disease susceptibility is associated with variants affecting the gene represented in this entry.
147050 OMIMAtopic hypersensitivity (ATOPY)A condition characterized by predisposition to develop hypersensitivity reactions. Atopic individuals can develop eczema, allergic rhinitis and allergic asthma. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB05119 RilapladibDrugbanksmall molecule
DB07821 (1R)-1,2,2-trimethylpropyl (R)-methylphosphinateDrugbanksmall molecule

Interactions

1 interaction

InteractorPartnerSourcesPublicationsLink
PAFA_HUMANTBA1A_HUMANHPRD9384577 details